Foundry Partners, LLC Ani Pharmaceuticals Inc Transaction History
Foundry Partners, LLC
- $1.82 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$174 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$77.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$53.7 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$48.2 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$47.4 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.14B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...